A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

NCT01629407 · clinicaltrials.gov ↗
COMPLETED
Status
315
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan